TY - JOUR
T1 - Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci
AU - Saxena, Richa
AU - Elbers, Clara C
AU - Guo, Yiran
AU - Peter, Inga
AU - Gaunt, Tom R
AU - Mega, Jessica L
AU - Lanktree, Matthew B
AU - Tare, Archana
AU - Castillo, Berta Almoguera
AU - Li, Yun R
AU - Johnson, Toby
AU - Bruinenberg, Marcel
AU - Gilbert-Diamond, Diane
AU - Rajagopalan, Ramakrishnan
AU - Voight, Benjamin F
AU - Balasubramanyam, Ashok
AU - Barnard, John
AU - Bauer, Florianne
AU - Baumert, Jens
AU - Bhangale, Tushar
AU - Böhm, Bernhard O
AU - Braund, Peter S
AU - Burton, Paul R
AU - Chandrupatla, Hareesh R
AU - Clarke, Robert
AU - Cooper-DeHoff, Rhonda M
AU - Crook, Errol D
AU - Davey-Smith, George
AU - Day, Ian N
AU - de Boer, Anthonius
AU - de Groot, Mark C H
AU - Drenos, Fotios
AU - Ferguson, Jane
AU - Fox, Caroline S
AU - Furlong, Clement E
AU - Gibson, Quince
AU - Gieger, Christian
AU - Gilhuijs-Pederson, Lisa A
AU - Glessner, Joseph T
AU - Goel, Anuj
AU - Gong, Yan
AU - Grant, Struan F A
AU - Grobbee, Diederick E
AU - Hastie, Claire
AU - Humphries, Steve E
AU - Newhouse, Stephen J
AU - Price, Thomas S
AU - Smith, Erin N
AU - Zhang, Li
AU - Wilson, James G
AU - Look AHEAD Research Group
N1 - Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
PY - 2012/3
Y1 - 2012/3
N2 - To identify genetic factors contributing to type 2 diabetes (T2D), we performed large-scale meta-analyses by using a custom ∼50,000 SNP genotyping array (the ITMAT-Broad-CARe array) with ∼2000 candidate genes in 39 multiethnic population-based studies, case-control studies, and clinical trials totaling 17,418 cases and 70,298 controls. First, meta-analysis of 25 studies comprising 14,073 cases and 57,489 controls of European descent confirmed eight established T2D loci at genome-wide significance. In silico follow-up analysis of putative association signals found in independent genome-wide association studies (including 8,130 cases and 38,987 controls) performed by the DIAGRAM consortium identified a T2D locus at genome-wide significance (GATAD2A/CILP2/PBX4; p = 5.7 × 10(-9)) and two loci exceeding study-wide significance (SREBF1, and TH/INS; p <2.4 × 10(-6)). Second, meta-analyses of 1,986 cases and 7,695 controls from eight African-American studies identified study-wide-significant (p = 2.4 × 10(-7)) variants in HMGA2 and replicated variants in TCF7L2 (p = 5.1 × 10(-15)). Third, conditional analysis revealed multiple known and novel independent signals within five T2D-associated genes in samples of European ancestry and within HMGA2 in African-American samples. Fourth, a multiethnic meta-analysis of all 39 studies identified T2D-associated variants in BCL2 (p = 2.1 × 10(-8)). Finally, a composite genetic score of SNPs from new and established T2D signals was significantly associated with increased risk of diabetes in African-American, Hispanic, and Asian populations. In summary, large-scale meta-analysis involving a dense gene-centric approach has uncovered additional loci and variants that contribute to T2D risk and suggests substantial overlap of T2D association signals across multiple ethnic groups.
AB - To identify genetic factors contributing to type 2 diabetes (T2D), we performed large-scale meta-analyses by using a custom ∼50,000 SNP genotyping array (the ITMAT-Broad-CARe array) with ∼2000 candidate genes in 39 multiethnic population-based studies, case-control studies, and clinical trials totaling 17,418 cases and 70,298 controls. First, meta-analysis of 25 studies comprising 14,073 cases and 57,489 controls of European descent confirmed eight established T2D loci at genome-wide significance. In silico follow-up analysis of putative association signals found in independent genome-wide association studies (including 8,130 cases and 38,987 controls) performed by the DIAGRAM consortium identified a T2D locus at genome-wide significance (GATAD2A/CILP2/PBX4; p = 5.7 × 10(-9)) and two loci exceeding study-wide significance (SREBF1, and TH/INS; p <2.4 × 10(-6)). Second, meta-analyses of 1,986 cases and 7,695 controls from eight African-American studies identified study-wide-significant (p = 2.4 × 10(-7)) variants in HMGA2 and replicated variants in TCF7L2 (p = 5.1 × 10(-15)). Third, conditional analysis revealed multiple known and novel independent signals within five T2D-associated genes in samples of European ancestry and within HMGA2 in African-American samples. Fourth, a multiethnic meta-analysis of all 39 studies identified T2D-associated variants in BCL2 (p = 2.1 × 10(-8)). Finally, a composite genetic score of SNPs from new and established T2D signals was significantly associated with increased risk of diabetes in African-American, Hispanic, and Asian populations. In summary, large-scale meta-analysis involving a dense gene-centric approach has uncovered additional loci and variants that contribute to T2D risk and suggests substantial overlap of T2D association signals across multiple ethnic groups.
U2 - 10.1016/j.ajhg.2011.12.022
DO - 10.1016/j.ajhg.2011.12.022
M3 - Article
C2 - 22325160
SN - 0002-9297
VL - 90
SP - 410
EP - 425
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -